GLP-1 & incretin peptides

Semaglutide analysis

Identity, vial amount, and method-defined chromatographic purity for declared semaglutide samples.

Identity mg/vial or stated basis Area %

Back to Peptides

Choose the sample form and any compatible add-ons below.

Base analysis

Included in this analytical scope

Reference-supported identity

Quantitative vial amount

Chromatographic purity

Sample form

Submission type

Optional measurements

Add compatible analyses.

Selections create a scope request, not a confirmed order. Compatibility and reporting basis are reviewed before sample shipment.

LC-MSLC-MS identity confirmationOrthogonal mass-spectral support for the declared molecular identity.CHNS / compositional modelNet peptide contentA separate compositional result that is not the same as HPLC area purity.LALBacterial endotoxinLAL measurement under stated conditions and on a defined reporting basis.TAMC / TYMCMicrobial enumerationTAMC and TYMC recovery under stated conditions; this is not a sterility test.Elemental screenElemental screeningSelected elemental signals within the agreed method and reporting capability.Matrix-appropriate methodCounter-ion determinationTargeted determination of an agreed counter-ion such as acetate or TFA when feasible.Potentiometric measurementpH measurementpH of a submitted solution or a sample reconstituted under an agreed procedure.DocumentationRaw-data packageAvailable chromatograms, spectra, and method-defined acquisition records supplied with the report.DocumentationAdditional issued reportA separately issued copy or reporting variant defined during scope review.

Semaglutide analysis

0 optional analyses selected

Analytical boundary: Chromatographic area purity is not automatically total chemical purity or percent by mass.

Need a different target?

Return to the full peptides catalog.

Browse all tests